{"id":"https://openalex.org/W2040769700","doi":"https://doi.org/10.1517/13543784.2011.566864","title":"Lysophosphatidic acid-1-receptor targeting agents for fibrosis","display_name":"Lysophosphatidic acid-1-receptor targeting agents for fibrosis","alternate_titles":[],"publication_year":2011,"publication_date":"2011-03-24","ids":{"openalex":"https://openalex.org/W2040769700","doi":"https://doi.org/10.1517/13543784.2011.566864","mag":"2040769700","pmid":"https://pubmed.ncbi.nlm.nih.gov/21434838"},"language":"en","primary_location":{"id":"doi:10.1517/13543784.2011.566864","doi":"https://doi.org/10.1517/13543784.2011.566864","is_oa":false,"landing_page_url":"https://doi.org/10.1517/13543784.2011.566864","pdf_url":null,"source":{"id":"https://openalex.org/S131064935","display_name":"Expert Opinion on Investigational Drugs","issn_l":"1354-3784","issn":["1354-3784","1744-7658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Investigational Drugs","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2040769700"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089436267","display_name":"C. Rancoule","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Chlo\u00e9 Rancoule","raw_affiliation_strings":["Inserm, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inserm, Toulouse, France","institution_ids":["https://openalex.org/I154526488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033308270","display_name":"Jean\u2010Philippe Prad\u00e8re","orcid":"https://orcid.org/0000-0003-1734-1429","observed_orcids":["https://orcid.org/0000-0003-1734-1429"]},"institutions":[{"id":"https://openalex.org/I78577930","display_name":"Columbia University","ror":"https://ror.org/00hj8s172","country_code":"US","type":"education","lineage":["https://openalex.org/I78577930"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jean-Philippe Prad\u00e8re","raw_affiliation_strings":["Columbia University, College of Physicians and Surgeons, Department of Medicine, NY 10032, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Columbia University, College of Physicians and Surgeons, Department of Medicine, NY 10032, USA","institution_ids":["https://openalex.org/I78577930"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076938715","display_name":"Julien Gonzalez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I134560555","display_name":"Universit\u00e9 Toulouse III - Paul Sabatier","ror":"https://ror.org/02v6kpv12","country_code":"FR","type":"education","lineage":["https://openalex.org/I134560555","https://openalex.org/I4405258862"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210147779","display_name":"Institut des Maladies M\u00e9taboliques et Cardiovasculaires","ror":"https://ror.org/04d73z393","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I4210147779","https://openalex.org/I4405258862"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Julien Gonzalez","raw_affiliation_strings":["Inserm, U1048/I2MC, 1 avenue Jean Poulh\u00e8s, BP 84225, 31432 Toulouse Cedex 4, France Jean-Sebastien.Saulnier-Blache@inserm.fr; Universit\u00e9 Toulouse III Paul Sabatier, Institut de M\u00e9decine Mol\u00e9culaire de Rangueil, Toulouse, F-31000 France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inserm, U1048/I2MC, 1 avenue Jean Poulh\u00e8s, BP 84225, 31432 Toulouse Cedex 4, France Jean-Sebastien.Saulnier-Blache@inserm.fr; Universit\u00e9 Toulouse III Paul Sabatier, Institut de M\u00e9decine Mol\u00e9culaire de Rangueil, Toulouse, F-31000 France","institution_ids":["https://openalex.org/I134560555","https://openalex.org/I154526488","https://openalex.org/I4210147779"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045393131","display_name":"Julie Klein","orcid":"https://orcid.org/0000-0002-3279-0559","observed_orcids":["https://orcid.org/0000-0002-3279-0559"]},"institutions":[{"id":"https://openalex.org/I134560555","display_name":"Universit\u00e9 Toulouse III - Paul Sabatier","ror":"https://ror.org/02v6kpv12","country_code":"FR","type":"education","lineage":["https://openalex.org/I134560555","https://openalex.org/I4405258862"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210147779","display_name":"Institut des Maladies M\u00e9taboliques et Cardiovasculaires","ror":"https://ror.org/04d73z393","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I4210147779","https://openalex.org/I4405258862"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Julie Klein","raw_affiliation_strings":["Inserm, U1048/I2MC, 1 avenue Jean Poulh\u00e8s, BP 84225, 31432 Toulouse Cedex 4, France Jean-Sebastien.Saulnier-Blache@inserm.fr; Universit\u00e9 Toulouse III Paul Sabatier, Institut de M\u00e9decine Mol\u00e9culaire de Rangueil, Toulouse, F-31000 France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inserm, U1048/I2MC, 1 avenue Jean Poulh\u00e8s, BP 84225, 31432 Toulouse Cedex 4, France Jean-Sebastien.Saulnier-Blache@inserm.fr; Universit\u00e9 Toulouse III Paul Sabatier, Institut de M\u00e9decine Mol\u00e9culaire de Rangueil, Toulouse, F-31000 France","institution_ids":["https://openalex.org/I134560555","https://openalex.org/I154526488","https://openalex.org/I4210147779"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088946409","display_name":"Philippe Valet","orcid":"https://orcid.org/0000-0001-6520-7393","observed_orcids":["https://orcid.org/0000-0001-6520-7393"]},"institutions":[{"id":"https://openalex.org/I134560555","display_name":"Universit\u00e9 Toulouse III - Paul Sabatier","ror":"https://ror.org/02v6kpv12","country_code":"FR","type":"education","lineage":["https://openalex.org/I134560555","https://openalex.org/I4405258862"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210147779","display_name":"Institut des Maladies M\u00e9taboliques et Cardiovasculaires","ror":"https://ror.org/04d73z393","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I4210147779","https://openalex.org/I4405258862"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Philippe Valet","raw_affiliation_strings":["Inserm, U1048/I2MC, 1 avenue Jean Poulh\u00e8s, BP 84225, 31432 Toulouse Cedex 4, France Jean-Sebastien.Saulnier-Blache@inserm.fr; Universit\u00e9 Toulouse III Paul Sabatier, Institut de M\u00e9decine Mol\u00e9culaire de Rangueil, Toulouse, F-31000 France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inserm, U1048/I2MC, 1 avenue Jean Poulh\u00e8s, BP 84225, 31432 Toulouse Cedex 4, France Jean-Sebastien.Saulnier-Blache@inserm.fr; Universit\u00e9 Toulouse III Paul Sabatier, Institut de M\u00e9decine Mol\u00e9culaire de Rangueil, Toulouse, F-31000 France","institution_ids":["https://openalex.org/I134560555","https://openalex.org/I154526488","https://openalex.org/I4210147779"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090325119","display_name":"Jean\u2010Loup Bascands","orcid":"https://orcid.org/0000-0002-1667-5913","observed_orcids":["https://orcid.org/0000-0002-1667-5913"]},"institutions":[{"id":"https://openalex.org/I134560555","display_name":"Universit\u00e9 Toulouse III - Paul Sabatier","ror":"https://ror.org/02v6kpv12","country_code":"FR","type":"education","lineage":["https://openalex.org/I134560555","https://openalex.org/I4405258862"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210147779","display_name":"Institut des Maladies M\u00e9taboliques et Cardiovasculaires","ror":"https://ror.org/04d73z393","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I4210147779","https://openalex.org/I4405258862"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jean-Loup Bascands","raw_affiliation_strings":["Inserm, U1048/I2MC, 1 avenue Jean Poulh\u00e8s, BP 84225, 31432 Toulouse Cedex 4, France Jean-Sebastien.Saulnier-Blache@inserm.fr; Universit\u00e9 Toulouse III Paul Sabatier, Institut de M\u00e9decine Mol\u00e9culaire de Rangueil, Toulouse, F-31000 France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inserm, U1048/I2MC, 1 avenue Jean Poulh\u00e8s, BP 84225, 31432 Toulouse Cedex 4, France Jean-Sebastien.Saulnier-Blache@inserm.fr; Universit\u00e9 Toulouse III Paul Sabatier, Institut de M\u00e9decine Mol\u00e9culaire de Rangueil, Toulouse, F-31000 France","institution_ids":["https://openalex.org/I134560555","https://openalex.org/I154526488","https://openalex.org/I4210147779"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009141968","display_name":"Joost Peter Schanstra","orcid":"https://orcid.org/0000-0002-7471-372X","observed_orcids":["https://orcid.org/0000-0002-7471-372X"]},"institutions":[{"id":"https://openalex.org/I134560555","display_name":"Universit\u00e9 Toulouse III - Paul Sabatier","ror":"https://ror.org/02v6kpv12","country_code":"FR","type":"education","lineage":["https://openalex.org/I134560555","https://openalex.org/I4405258862"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210147779","display_name":"Institut des Maladies M\u00e9taboliques et Cardiovasculaires","ror":"https://ror.org/04d73z393","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I4210147779","https://openalex.org/I4405258862"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Joost P Schanstra","raw_affiliation_strings":["Inserm, U1048/I2MC, 1 avenue Jean Poulh\u00e8s, BP 84225, 31432 Toulouse Cedex 4, France Jean-Sebastien.Saulnier-Blache@inserm.fr; Universit\u00e9 Toulouse III Paul Sabatier, Institut de M\u00e9decine Mol\u00e9culaire de Rangueil, Toulouse, F-31000 France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inserm, U1048/I2MC, 1 avenue Jean Poulh\u00e8s, BP 84225, 31432 Toulouse Cedex 4, France Jean-Sebastien.Saulnier-Blache@inserm.fr; Universit\u00e9 Toulouse III Paul Sabatier, Institut de M\u00e9decine Mol\u00e9culaire de Rangueil, Toulouse, F-31000 France","institution_ids":["https://openalex.org/I134560555","https://openalex.org/I154526488","https://openalex.org/I4210147779"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5046862355","display_name":"Jean S\u00e9bastien Saulnier\u2010Blache","orcid":"https://orcid.org/0000-0002-8971-7723","observed_orcids":["https://orcid.org/0000-0002-8971-7723"]},"institutions":[{"id":"https://openalex.org/I134560555","display_name":"Universit\u00e9 Toulouse III - Paul Sabatier","ror":"https://ror.org/02v6kpv12","country_code":"FR","type":"education","lineage":["https://openalex.org/I134560555","https://openalex.org/I4405258862"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210147779","display_name":"Institut des Maladies M\u00e9taboliques et Cardiovasculaires","ror":"https://ror.org/04d73z393","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I4210147779","https://openalex.org/I4405258862"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jean-S\u00e9bastien Saulnier-Blache","raw_affiliation_strings":["Inserm, U1048/I2MC, 1 avenue Jean Poulh\u00e8s, BP 84225, 31432 Toulouse Cedex 4, France Jean-Sebastien.Saulnier-Blache@inserm.fr; Universit\u00e9 Toulouse III Paul Sabatier, Institut de M\u00e9decine Mol\u00e9culaire de Rangueil, Toulouse, F-31000 France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inserm, U1048/I2MC, 1 avenue Jean Poulh\u00e8s, BP 84225, 31432 Toulouse Cedex 4, France Jean-Sebastien.Saulnier-Blache@inserm.fr; Universit\u00e9 Toulouse III Paul Sabatier, Institut de M\u00e9decine Mol\u00e9culaire de Rangueil, Toulouse, F-31000 France","institution_ids":["https://openalex.org/I134560555","https://openalex.org/I154526488","https://openalex.org/I4210147779"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.7432,"has_fulltext":false,"cited_by_count":93,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.57706555,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"20","issue":"5","first_page":"657","last_page":"667"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11308","display_name":"Sphingolipid Metabolism and Signaling","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11308","display_name":"Sphingolipid Metabolism and Signaling","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11330","display_name":"Systemic Sclerosis and Related Diseases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10870","display_name":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lysophosphatidic-acid","display_name":"lysophosphatidic acid","score":0.9909999966621399},{"id":"https://openalex.org/keywords/lpa1-receptor","display_name":"LPA1 receptor","score":0.902999997138977},{"id":"https://openalex.org/keywords/lysophosphatidic-acid-receptor","display_name":"lysophosphatidic acid receptor","score":0.7979999780654907},{"id":"https://openalex.org/keywords/fibrosis","display_name":"fibrosis","score":0.7829999923706055},{"id":"https://openalex.org/keywords/antifibrotic-agents","display_name":"antifibrotic agents","score":0.9419999718666077},{"id":"https://openalex.org/keywords/g-protein-coupled-receptors","display_name":"G protein-coupled receptors","score":0.8529999852180481},{"id":"https://openalex.org/keywords/renal-fibrosis","display_name":"renal fibrosis","score":0.878000020980835},{"id":"https://openalex.org/keywords/pulmonary-fibrosis","display_name":"pulmonary fibrosis","score":0.9520000219345093},{"id":"https://openalex.org/keywords/liver-fibrosis","display_name":"liver fibrosis","score":0.9100000262260437},{"id":"https://openalex.org/keywords/systemic-sclerosis","display_name":"systemic sclerosis","score":0.8109999895095825},{"id":"https://openalex.org/keywords/skin-fibrosis","display_name":"skin fibrosis","score":0.7590000033378601},{"id":"https://openalex.org/keywords/vascular-fibrosis","display_name":"vascular fibrosis","score":0.6710000038146973}],"concepts":[{"id":"https://openalex.org/C2776661833","wikidata":"https://www.wikidata.org/wiki/Q2823281","display_name":"Lysophosphatidic acid","level":3,"score":0.8378512859344482},{"id":"https://openalex.org/C2780559512","wikidata":"https://www.wikidata.org/wiki/Q605709","display_name":"Fibrosis","level":2,"score":0.7444736957550049},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6102774739265442},{"id":"https://openalex.org/C2777214474","wikidata":"https://www.wikidata.org/wiki/Q147778","display_name":"Cirrhosis","level":2,"score":0.5614930987358093},{"id":"https://openalex.org/C2781244666","wikidata":"https://www.wikidata.org/wiki/Q32446","display_name":"Pulmonary fibrosis","level":3,"score":0.4165576696395874},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.41141775250434875},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.37203919887542725},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.35399699211120605},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3395978808403015},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.33491116762161255},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.28410735726356506},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.25688624382019043}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005355","descriptor_name":"Fibrosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008246","descriptor_name":"Lysophospholipids","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D008246","descriptor_name":"Lysophospholipids","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D049368","descriptor_name":"Receptors, Lysophosphatidic Acid","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D049368","descriptor_name":"Receptors, Lysophosphatidic Acid","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D058990","descriptor_name":"Molecular Targeted Therapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1517/13543784.2011.566864","doi":"https://doi.org/10.1517/13543784.2011.566864","is_oa":false,"landing_page_url":"https://doi.org/10.1517/13543784.2011.566864","pdf_url":null,"source":{"id":"https://openalex.org/S131064935","display_name":"Expert Opinion on Investigational Drugs","issn_l":"1354-3784","issn":["1354-3784","1744-7658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Investigational Drugs","raw_type":"journal-article"},{"id":"pmid:21434838","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21434838","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on investigational drugs","raw_type":"Journal Article"},{"id":"pmh:oai:HAL:inserm-00617587v1","doi":null,"is_oa":false,"landing_page_url":"https://inserm.hal.science/inserm-00617587","pdf_url":null,"source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Expert Opinion on Investigational Drugs, 2011, 20 (5), pp.657-67. &#x27E8;10.1517/13543784.2011.566864&#x27E9;","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":126,"referenced_works":["https://openalex.org/W40836733","https://openalex.org/W103448961","https://openalex.org/W123610432","https://openalex.org/W1492778318","https://openalex.org/W1512600725","https://openalex.org/W1582393841","https://openalex.org/W1598234991","https://openalex.org/W1653800962","https://openalex.org/W1747569172","https://openalex.org/W1870053867","https://openalex.org/W1969870436","https://openalex.org/W1974949452","https://openalex.org/W1980325398","https://openalex.org/W1981269419","https://openalex.org/W1985602371","https://openalex.org/W1986329495","https://openalex.org/W1989792558","https://openalex.org/W1990104149","https://openalex.org/W1992203600","https://openalex.org/W1996783930","https://openalex.org/W1997670710","https://openalex.org/W1998064289","https://openalex.org/W1998712143","https://openalex.org/W2000331273","https://openalex.org/W2005959847","https://openalex.org/W2010677570","https://openalex.org/W2018202653","https://openalex.org/W2025240578","https://openalex.org/W2025785613","https://openalex.org/W2026202377","https://openalex.org/W2026756516","https://openalex.org/W2026827182","https://openalex.org/W2027924835","https://openalex.org/W2030048684","https://openalex.org/W2030505808","https://openalex.org/W2031309839","https://openalex.org/W2034150400","https://openalex.org/W2036471410","https://openalex.org/W2036899152","https://openalex.org/W2047709095","https://openalex.org/W2049368468","https://openalex.org/W2049494923","https://openalex.org/W2051655075","https://openalex.org/W2051772841","https://openalex.org/W2051838887","https://openalex.org/W2052912009","https://openalex.org/W2053504505","https://openalex.org/W2059988907","https://openalex.org/W2060043024","https://openalex.org/W2063159737","https://openalex.org/W2063695842","https://openalex.org/W2063865897","https://openalex.org/W2064256960","https://openalex.org/W2067789393","https://openalex.org/W2069525354","https://openalex.org/W2069787785","https://openalex.org/W2073049822","https://openalex.org/W2076095413","https://openalex.org/W2078475280","https://openalex.org/W2081741824","https://openalex.org/W2083180345","https://openalex.org/W2084495003","https://openalex.org/W2084676297","https://openalex.org/W2084961895","https://openalex.org/W2086244192","https://openalex.org/W2087823408","https://openalex.org/W2088891151","https://openalex.org/W2090938411","https://openalex.org/W2091508582","https://openalex.org/W2091693886","https://openalex.org/W2093461295","https://openalex.org/W2095200469","https://openalex.org/W2098565708","https://openalex.org/W2098615703","https://openalex.org/W2100303404","https://openalex.org/W2100429415","https://openalex.org/W2105748632","https://openalex.org/W2106469057","https://openalex.org/W2108872143","https://openalex.org/W2109680888","https://openalex.org/W2116060153","https://openalex.org/W2121259551","https://openalex.org/W2123627277","https://openalex.org/W2123926637","https://openalex.org/W2124900560","https://openalex.org/W2127865222","https://openalex.org/W2128585253","https://openalex.org/W2129351604","https://openalex.org/W2131032222","https://openalex.org/W2132386429","https://openalex.org/W2136326008","https://openalex.org/W2136425420","https://openalex.org/W2137233845","https://openalex.org/W2139891775","https://openalex.org/W2140800784","https://openalex.org/W2142988890","https://openalex.org/W2143141083","https://openalex.org/W2143551777","https://openalex.org/W2143582908","https://openalex.org/W2143633302","https://openalex.org/W2143959929","https://openalex.org/W2145221446","https://openalex.org/W2145739766","https://openalex.org/W2147321167","https://openalex.org/W2149310803","https://openalex.org/W2149439788","https://openalex.org/W2151051006","https://openalex.org/W2153435592","https://openalex.org/W2156303710","https://openalex.org/W2159374668","https://openalex.org/W2159623504","https://openalex.org/W2160870763","https://openalex.org/W2161184363","https://openalex.org/W2163549706","https://openalex.org/W2166375403","https://openalex.org/W2166457225","https://openalex.org/W2166640328","https://openalex.org/W2167213027","https://openalex.org/W2186748399","https://openalex.org/W2188165345","https://openalex.org/W2321774350","https://openalex.org/W2400937798","https://openalex.org/W2404746307","https://openalex.org/W2460918827","https://openalex.org/W4211047743","https://openalex.org/W4406056548"],"related_works":["https://openalex.org/W4297988396","https://openalex.org/W2058011131","https://openalex.org/W4407164304","https://openalex.org/W2063159737","https://openalex.org/W2914548013","https://openalex.org/W2103280869","https://openalex.org/W2080679386","https://openalex.org/W4400211491","https://openalex.org/W4406739972","https://openalex.org/W2055091004"],"abstract_inverted_index":{"INTRODUCTION:":[0],"The":[1,138],"presence":[2],"of":[3,18,38,67,84,89,104,115,125,131,140,174,185,196],"fibrosis":[4,91,144],"is":[5,13,92,145,191],"associated":[6,93],"with":[7,94,101,118],"alterations":[8],"in":[9,57,81,142,155,201],"organ":[10],"architecture":[11],"and":[12,32,42,113,135,194],"responsible":[14],"for":[15,171],"the":[16,65,82,123,129,172,183],"morbidity":[17],"diseases":[19,31],"including":[20],"pneumopathies,":[21],"systemic":[22],"sclerosis,":[23],"liver":[24,143],"cirrhosis,":[25],"chronic":[26],"cardiovascular":[27],"diseases,":[28],"progressive":[29],"kidney":[30],"diabetes.":[33],"Although":[34],"a":[35,71,87],"growing":[36],"number":[37,88,184],"pro-fibrotic":[39],"molecules,":[40],"mediators":[41],"other":[43],"pathways":[44],"have":[45,163],"been":[46,199],"reported,":[47],"there":[48],"are":[49],"currently":[50,189],"very":[51],"few":[52],"antifibrotic":[53],"molecules":[54],"being":[55],"evaluated":[56],"clinical":[58,202],"trials.":[59],"AREAS":[60],"COVERED:":[61],"Current":[62],"knowledge":[63],"about":[64],"contribution":[66,124],"lysophosphatidic":[68],"acid":[69],"(LPA),":[70],"bioactive":[72],"mediator":[73],"acting":[74],"via":[75],"specific":[76,119],"G-protein":[77],"coupled":[78],"receptors":[79],"(LPAR),":[80],"etiology":[83],"fibrosis.":[85,137],"In":[86],"organs,":[90],"increased":[95,102],"LPA":[96,141],"production":[97],"as":[98,100],"well":[99],"expression":[103],"some":[105],"LPAR":[106],"subtypes":[107],"(mainly":[108],"LPA1R).":[109],"LPAR(-/-)":[110],"knockout":[111],"mice":[112],"treatment":[114],"animal":[116,156],"models":[117,157],"antagonists":[120,162,188],"clearly":[121,158],"demonstrate":[122,159],"LPA1R":[126,161,187],"subtype":[127],"to":[128,178],"development":[130],"kidney,":[132],"lung,":[133],"vascular":[134],"dermal":[136],"involvement":[139],"also":[146],"strongly":[147],"suspected":[148],"but":[149],"still":[150,192],"unproven.":[151],"EXPERT":[152],"OPINION:":[153],"Experiments":[154],"that":[160],"interesting":[164],"anti-fibrotic":[165],"potencies.":[166],"This":[167],"reveals":[168],"promising":[169],"perspectives":[170],"design":[173],"new":[175],"therapeutic":[176],"approaches":[177],"prevent":[179],"fibrosis-associated":[180],"diseases.":[181],"Nevertheless,":[182],"efficient":[186],"available":[190],"low,":[193],"none":[195],"them":[197],"has":[198],"used":[200],"trials":[203],"so":[204],"far.":[205]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2040769700","counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":9},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":9},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":10},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":8}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
